Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Renovaro Biosciences ( (RENB) ) just unveiled an update.
Lunai Bioworks, Inc. announced a 1-for-10 reverse stock split of its common stock, which will take effect on September 29, 2025. This corporate action, approved by the majority of stockholders on August 15, 2025, will reduce the number of outstanding shares from approximately 231.8 million to 23.2 million, while maintaining the authorized shares at 350 million. The reverse stock split aims to consolidate shares without altering the par value and will see the stock begin trading on a split-adjusted basis on Nasdaq on September 30, 2025.
More about Renovaro Biosciences
Average Trading Volume: 1,879,948
Technical Sentiment Signal: Sell
Current Market Cap: $39.86M
For an in-depth examination of RENB stock, go to TipRanks’ Overview page.